Blueprint Medicines Corp BPMC Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300
Summary
Blueprint Medicines Corp Blueprint is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU285, for treatment resistant gastrointestinal stromal tumors; BLU554, used in hepatocellular carcinoma; BLU667, for retmutations, fusions, and predicted resistant mutants, rare genetic disease target, immunokinase targets, and others. Blueprint identifies drug targets by sequencing cancers and mining public data with new genome analysis algorithms. It operates through genomic and cancer research institutions located in the US. Blueprint is headquartered in Cambridge, Massachusetts, the US.
Blueprint Medicines Corp Key Recent Developments
Oct 31,2017: Blueprint Medicines Reports Third Quarter 2017 Financial Results
Oct 10,2017: Blueprint Medicines Announces Appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations
Aug 02,2017: Blueprint Medicines Q2 net loss up
Aug 02,2017: Blueprint Medicines Reports Second Quarter 2017 Financial Results
Jul 27,2017: Blueprint Medicines to Evaluate Opportunities to Advance Rare Disease Discovery Program in Fibrodysplasia Ossificans Progressiva Following Discontinuation of Collaboration with Alexion
This comprehensive SWOT profile of Blueprint Medicines Corp provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Blueprint Medicines Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.
The profile contains critical company information including*,
Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Original Article: Blueprint Medicines Corp BPMC Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300
